RxDoctor Payments Data

Charles Chiu

Infectious Disease · San Francisco, CANPI 1598797268

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $10,105 of the $13,449 with a category attached, or 75.1%. Reporting peaked in 2020 at $8,110 and has fallen 99.3% since, to $54 in 2024. Among infectious disease clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$13,449in general payments, 2019–2025

Across 20 payments — averaging $672.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Cepheid$8K
  • Abbott$5K
$962,500in research payments, 2019–2025

Across 3 payments — averaging $320,833 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Abbott$963K

What the payments were for

  • Consulting fees$10,10575%
  • Travel & lodging$3,12023%
  • Food & beverage$2242%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Cepheid3$7,980
Abbott17$5,469

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,449 in reported general payments places this provider in the 90th percentile of 856 infectious disease providers in California.

See all infectious disease providers in California →

Other infectious disease in San Francisco

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →